About
ProSciento’s state-of-the-art clinical research unit (CRU) specializes in metabolic studies and is located in Chula Vista, CA. Since 2003, the CRU has conducted more than 300 clinical research studies in NASH, diabetes, obesity, and related metabolic diseases for small and large molecule therapies, biologics, biosimilars, and medical devices. Research conducted at the CRU has been at the forefront of metabolic clinical research, contributing to the development of advanced methodologies, including imaging and circulating biomarkers, glucose clamp procedures, tracer studies, and glucose monitoring systems.

Recommended Materials

Posters
Impact of praliciguat, a soluble guanylate cyclase stimulator, on blood pressure and metabolic parameters in patients with diabetes and hypertension

Articles
Short-term metabolic effects of prednisone administration in healthy subjects

Fact Sheets
Automated Glucose Clamp Procedures for Diabetes Clinical Research
Related Solutions

Our Services
